Intestinal Rehabilitation and Transplant Association Update

Paris was the beautiful setting for the 16th International Congress of the Intestinal Rehabilitation and Transplant Association which was held on July 3-6, 2019. Over 600 participants from 38 countries enjoyed the spectacular scientific program ( Highlights of the Congress included very interactive video surgical sessions, workshops on post-transplant monitoring, endoscopy and pathology criteria as well as balanced didactic and new abstract presentations. Stay tuned to the IRTA Section on for the session recordings available to members. We extend a huge thanks to Florence LaCaille and the local team for their passion and focus in planning a fantastic program.

IRTA Council 2019-2021

Left to right: George Mazariegos, Laurens Ceulemans, Gabriel Gondolesi, Matt Everly, Jonathan Hind, Beverly Kocmach-Park, Simon Horslen, Florence Lacaille, Debra Sudan, Yaron Avitzur, Taizo Hibi, Helen Evans, Amin Roberts, Robert Venick, Palle Bekker Jeppesen, Rodrigo Vianna

The IRTA Council also met for a day of strategic planning to refine the Association’s Vision, Mission and Values. And the planning is underway for the next Congress in Auckland, New Zealand! Finally, The IRTA welcomed Simon Horslen as the new IRTA President. Thank you to the Council for the investment and work in the Association.

Paris was a superb setting for the meeting which was capped off with a beautiful 3-hour cruise along the River Seine. We welcome new members to the IRTA at as we continue the development of the field of intestine rehabilitation and transplantation!  

2019 TTS-IRTA Award Winners

  • Arpit Amin
    University of California Los Angeles, USA
    Pre-, Peri-, and Post-Operative Predictors of Survival after Intestinal Transplantation: Results from a Single-Center Analysis
  • Irum Amin
    Cambridge University Hospitals NHS Foundation, UK
    Use of Arterial Embolisation to Facilitate Exenteration during Multi-visceral and Intestinal Transplantation
  • Alba Bueno
    La Paz Universitary Hospital, Spain
    The Use Of Alemtuzumab as Immunosuppressive Induction in Intestinal Transplantation among Pediatric Population
  • Emilio Canovai
    University Hospitals Leuve, Belgium
    Int 767 – A Novel Dual Farnesoid-X Receptor (Fxr) and Takeda G-Protein-Coupled Receptor-5 (Tgr5) Agonist Attenuates Intestinal Ischemia Reperfusion Injury
  • Kim Herbison
    Starship Children's Hospital, New Zealand
    Intestinal Failure in a Tertiary Children’s Hospital Before and after the Establishment of a National Intestinal Failure Service; Incidence, Aetiology and Outcome
  • María Inés Martínez, Caroline Rumbo
    Hospital Universitario Fundacion Favaloro, Argentina
    Long Term Results of a Series of Pediatric Patients with Short Bowel Syndrome Treated at an Intestinal Failure, Rehabilitation and Transplant Program
  • Vikram Raghu
    UPMC Children's Hospital of Pittsburgh, USA
    Intestinal Failure in a Tertiary Children’s Hospital Before and After the Establishment of a National Intestinal Failure Service; Incidence, Aetiology And Outcome
  • Stephanie So
    The Hospital for Sick Children, Canada
    Physical Activity, Strength and Fatigue in Children with Intestinal Failure On Parenteral Nutrition
  • Pablo Stringa
    Instituto De Estudios Inmunologicos Y Fisiopatologicos, Argentina
    Native Spleen Preservation Attenuate Graft Versus Host Disease in an Experimental Model of Modified Multivisceral Transplantation
  • Elizabeth Waffarn
    Columbia Univeristy, USA
    Dynamic Repopulation, Phenotypic Evolution and Clonal Distribution of Recipient B Cells and Plasma Cells in Graft Mucosa Associated with Rejection after Human Intestinal Transplantation
  • Fangfang Wang
    University of Nebraska Nebraska, USA
    Glucocorticoid Treatment Improves Enteral Feeding Tolerance in Pediatric Short Bowel Syndrome Patients with Chronic Intestinal Inflammatory Changes